Plain-English translation of NCT00912041 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
BrainGate2 is testing an experimental implant called the BrainGate Neural Interface System that is placed in the brain to help people with severe paralysis communicate and control devices like computers or robotic limbs. The implant works by reading brain signals and translating them into commands, potentially restoring abilities that people have lost due to paralysis. This research aims to develop a medical device that could give people with conditions like spinal cord injury or ALS back some of their independence.
Many people with severe paralysis lose the ability to move their bodies or speak, which can be isolating and limit their independence. This trial exists to test whether a direct brain-computer interface can safely help restore communication and control of external devices for people with these conditions.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will undergo surgery to have the BrainGate implant placed in your brain, followed by a recovery period. After that, you will have regular visits to the research site where you will work with the implant system, learning to use brain signals to control computers or other devices, while researchers monitor your progress and safety. The study involves ongoing training sessions and assessments over an extended period.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States